JESSICA WITHROW: Open Payments
NPI 1548803273 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$303 in 13 payments from 11 companies in 2025. Trend: 2023 $285 · 2024 $313 · 2025 $303
Food & beverage: $303
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 2 | $49 |
| AstraZeneca Pharmaceuticals LP | 2 | $47 |
| SCPHARMACEUTICALS INC. | 1 | $42 |
| ABIOMED | 1 | $34 |
| Boston Scientific Corporation | 1 | $27 |
| Vital Connect, Inc | 1 | $21 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $21 |
| Philips North America LLC | 1 | $17 |
| Novartis Pharmaceuticals Corporation | 1 | $17 |
| PFIZER INC. | 1 | $15 |
Products named: Wegovy, FARXIGA, FUROSCIX, WATCHMAN FLX, VITALPATCH RTM, Kerendia, Ambulatory Monitoring & Diagnostics Undivided, LEQVIO.
Industry payments across KY — which companies pay providers there.
